Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  New England Journal of Medicine

• Publication date

  2006-09-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJMOA062598PMID 16971717
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients.

  2006cited by this paper
• Sirolimus-eluting versus uncoated stents in acute myocardial infarction.

  2006cited by this paper
• Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial.

  2005cited by this paper
• Diabetic keto-acidosis and hyperkalaemia induced pseudo-myocardial infarction

  2005cited by this paper
• Impact of sirolimus‐eluting stents on outcomes of patients treated for acute myocardial infarction by primary angioplasty

  2005cited by this paper
• Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction.

  2004cited by this paper
• A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.

  2004cited by this paper
• Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

  2003cited by this paper
• Sirolimus-Eluting Stent Implantation in ST-Elevation Acute Myocardial Infarction: A Clinical and Angiographic Study

  2003cited by this paper
• Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for Coronary Artery Lesions

  2003cited by this paper
• A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.

  2002cited by this paper
• A RANDOMIZED COMPARISON OF A SIROLIMUS-ELUTING STENT WITH A STANDARD STENT FOR CORONARY REVASCULARIZATION

  2002cited by this paper
• Primary stent implantation compared with primary balloon angioplasty for acute myocardial infarction: a meta-analysis of randomized clinical trials.

  2001cited by this paper
• Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group.

  2000cited by this paper
• Long-term benefit of primary angioplasty compared to thrombolytic therapy for acute myocardial infarction.

  2000cited by this paper
• Coronary Angioplasty with or without Stent Implantation for Acute Myocardial Infarction

  1999cited by this paper
• Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction.

  1999cited by this paper
• Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review.

  1998cited by this paper
• A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction.

  1997cited by this paper
• Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction : A quantitative review

  1997cited by this paper
• The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

  1985cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Biofunctional coatings and drug-coated stents for restenosis therapy

  2024cites this paper
• Evolución en la atención del IAMCEST en una región de España: un reflejo de las mejoras conseguidas en el siglo XXI

  2024cites this paper
• CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2024

  2024cites this paper
• CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022

  2022cites this paper
• Drug-Eluting Stents Versus Bare-Metal Stents in Diabetic Patients With ST-Segment Elevation Acute Myocardial Infarction: A Pooled Analysis of Individual Patient Data From 7 Randomized Trials

  2022influential citation
• Drug-Eluting Stents Versus Bare-Metal Stents in Diabetic Patients With ST-Segment Elevation Acute Myocardial Infarction: A Pooled Analysis of Individual Patient Data From 7 Randomized Trials

  2022influential citation
• Drug-Eluting Stents Versus Bare-Metal Stents in Diabetic Patients With ST-Segment Elevation Acute Myocardial Infarction: A Pooled Analysis of Individual Patient Data From 7 Randomized Trials

  2022influential citation
• Drug-Eluting Stents Versus Bare-Metal Stents in Diabetic Patients With ST-Segment Elevation Acute Myocardial Infarction: A Pooled Analysis of Individual Patient Data From 7 Randomized Trials

  2022influential citation
• OUTCOME OF PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION ARRIVING IN ARMY CARDIAC CENTER LAHORE

  2021cites this paper
• Cardiología intervencionista

  2020cites this paper
• IAM

  2020cites this paper
• Validity of the Stent Thrombosis Risk Score in Predicting Early Stent Thrombosis after Primary Percutaneous Coronary Intervention

  2020cites this paper
• The 2010s in clinical drug-eluting stent and bioresorbable scaffold research: a Dutch perspective

  2020cites this paper
• Drug Eluting Stents versus Bare Metal Stents in ST- Segment Elevation Myocardial Infarction

  2019cites this paper
• Efficacy and safety of drug-eluting stents in elderly patients: A meta-analysis of randomized trials

  2019cites this paper
• Study of efficacy and safety of drug eluting stent versus bare metal stent in ST elevation MI

  2019cites this paper
• Long-Term Efficacy and Safety of Everolimus-Eluting Stent Implantation in Japanese Patients with Acute Coronary Syndrome: Five-Year Real-World Data from the Tokyo-MD PCI Study

  2019cites this paper
• Acute Myocardial Infarction

  2019cites this paper
• Acute and sub-acute stent thrombosis: Frequency, predictors and features in patients undergoing primary percutaneous intervention at a tertiary care cardiac centre

  2019cites this paper
• Drug-eluting stents compared to bare-metal stents improve mortality in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention - A Nationwide Prospective Analysis of AMIS

  2018cites this paper
• Identification of functional modules induced by bare-metal stents and paclitaxel-eluting stents in coronary heart disease

  2018cites this paper
• Short- and long-term clinical impact of tissue protrusion after newer-generation drug-eluting stent implantation for acute coronary syndrome

  2018cites this paper
• The evolution of coronary stents

  2018cites this paper
• Long-term safety of bioresorbable scaffolds: insights from a network meta-analysis including 91 trials.

  2018cites this paper
• Comparison of 5‐year outcomes of paclitaxel‐eluting and endeavor zotarolimus‐eluting stents in New York

  2018cites this paper
• CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) in 2018

  2018cites this paper
• Experience and Outcomes of Primary Percutaneous Coronary Intervention for Patients with ST-Segment Elevation Myocardial Infarction of Tertiary Care Center in Bosnia and Herzegovina

  2017cites this paper
• Comparison of two biodegradable‐polymer‐based sirolimus‐eluting stents with varying elution and absorption kinetics in patients with acute myocardial infarction: A subgroup analysis of the PANDA III trial

  2017cites this paper
• Drug-eluting stents versus bare-metal stents for acute coronary syndrome.

  2017cites this paper
• Long-term comparative effectiveness of paclitaxel-eluting and everolimus-eluting stents in New York.

  2017cites this paper
• Comparison of Angioplasty With Infusion ofTirofibanorAbciximabandWithImplantation of Sirolimus-Eluting or Uncoated Stents for Acute Myocardial Infarction

  2017cites this paper
• Understanding the e ff ect of magnesium degradation on drug release and anti-proliferation on smooth muscle cells for magnesium-based drug eluting stents

  2017cites this paper
• Long Term Follow up of a Carbofilm Coated Stent in ST-Elevation Myocardial Infarction: Insight from the Real World SAVONA Registry

  2017cites this paper
• Comparación de la angioplastia primaria frente a la angioplastia post-fibrinolisis en pacientes con infarto agudo de miocardio con elevación del segmento ST. El ensayo clínico GRACIA 4

  2017influential citation
• 3D‐Printed Multidrug‐Eluting Stent from Graphene‐Nanoplatelet‐Doped Biodegradable Polymer Composite

  2017cites this paper
• Hierarchical testing of composite endpoints: applying the win ratio to percutaneous coronary intervention versus coronary artery bypass grafting in the SYNTAX trial.

  2017cites this paper
• In vitro and in vivo degradation of rapamycin-eluting Mg-Nd-Zn-Zr alloy stents in porcine coronary arteries.

  2017cites this paper
• Understanding the effect of magnesium degradation on drug release and anti-proliferation on smooth muscle cells for magnesium-based drug eluting stents

  2017cites this paper
• Five‐year follow‐up of polymer‐free sirolimus‐ and probucol‐eluting stents versus new generation zotarolimus‐eluting stents in patients presenting with st‐elevation myocardial infarction

  2017cites this paper
• Historical Perspective of Sirolimus and Paclitaxel‐Eluting Stent Clinical Studies

  2016cites this paper
• Simulation of heparin distribution in an injured coronary artery

  2016cites this paper
• Role of BMS in Des ERA

  2016cites this paper
• Long‐term outcomes following drug‐eluting stents versus bare metal stents for primary percutaneous coronary intervention: A real‐world analysis of 11,181 patients from the british columbia cardiac registry

  2016cites this paper
• Randomised comparison of drug-eluting versus bare-metal stenting in patients with non-ST elevation myocardial infarction

  2016cites this paper
• Current State of ST-Segment Myocardial Infarction: Evidence-based Therapies and Optimal Patient Outcomes in Advanced Systems of Care.

  2016cites this paper
• Randomized Clinical Trials and Observational Studies

  2016cites this paper
• REVascularization with paclitaxEL‐coated balloon angioplasty versus drug‐eluting stenting in acute myocardial infarcTION—A randomized controlled trial: Rationale and design of the REVELATION trial

  2016cites this paper
• Endovascular drug-delivery and drug-elution systems

  2016cites this paper
• The TITAN-AMI multicenter registry evaluating the usage of Titan2 stent in patients with ST segment elevation myocardial infarction. Final result at 12-month follow-up.

  2015cites this paper
• Impact of preprocedural high-sensitive C-reactive protein levels on long-term clinical outcomes of patients with stable coronary artery disease and chronic kidney disease who were treated with drug-eluting stents.

  2015cites this paper
• TIDES-ACS Trial: comparison of titanium-nitride-oxide coated bio-active-stent to the drug (everolimus)-eluting stent in acute coronary syndrome. Study design and objectives.

  2015cites this paper
• Impact of gender difference on PCI outcome in Egyptian diabetic patients: Prospective two center registry study

  2015cites this paper
• Everolimus-Eluting Stents Reduce Monocyte Expression of Toll-Like Receptor 4.

  2015cites this paper
• Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes.

  2015cites this paper
• WITHDRAWN: Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes.

  2015cites this paper
• One-year clinical outcomes of the STENTYS Self-Apposing¨ coronary stent in patients presenting with ST-segment elevation myocardial infarction: results from the APPOSITION III registry.

  2015cites this paper
• Recurrent Myocardial Infarction After Primary Percutaneous Coronary Intervention in Multivessel Coronary Disease Is Primarily Related to Stent Failure: Post-Hoc Analysis of the PASSION Trial.

  2015cites this paper
• Curcumin Attenuates Rapamycin-induced Cell Injury of Vascular Endothelial Cells

  2015cites this paper
• Safety and efficacy of first-generation and second-generation drug-eluting stents in the setting of acute coronary syndromes

  2014cites this paper
• General introduction and outline of the thesis

  2014cites this paper
• Comparison between drug-eluting and bare metal stent on ST-elevation myocardial infarction outcome: should second-generation drug-eluting stent be preferred?

  2014cites this paper
• Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted Fro

  2014cites this paper
• Drug-eluting stents compared to bare-metal stents improve short-term survival in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a nationwide prospective analysis of the AMIS Plus registry.

  2014cites this paper
• Five-year outcomes for first generation drug-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: a meta-analysis of randomised controlled trials.

  2014cites this paper
• Second-generation versus first-generation drug-eluting stents for the treatment of patients with acute coronary syndromes and obstructive coronary artery disease

  2014cites this paper
• Is there enough evidence for routine use of drug-eluting stents in acute myocardial infarction with ST segment elevation?

  2014cites this paper
• Improving smooth muscle cell exposure to drugs from drug-eluting stents at early time points: a variable compression approach

  2014cites this paper
• Long-term Clinical and Angiographic Outcomes after Primary Stenting for ST Segment Elevation Myocardial Infarction Using a Paclitaxel-Eluting Stent: A Propensity Score-Matched Comparison with Bare-Metal Stents (Original)

  2014cites this paper
• Understanding the Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery (SYNTAX) Trial Implications for current and future clinical practice

  2014cites this paper
• Use of drug-eluting stents in acute myocardial infarction with persistent ST-segment elevation: results of the ALKK PCI-registry

  2014cites this paper
• New generation drug‐eluting stents for ST‐elevation myocardial infarction: A new paradigm for safety

  2014cites this paper
• Biodegradable polymer Biolimus-eluting stent (Nobori®) for the treatment of coronary artery lesions: review of concept and clinical results

  2014cites this paper
• Safety and feasibility of a PAclitaxel-eluting balloon angioplasty in Primary Percutaneous coronary intervention in Amsterdam (PAPPA): one-year clinical outcome of a pilot study.

  2014cites this paper
• Drug-eluting stents for ST-elevation myocardial infarction: ready for prime time?

  2014cites this paper
• Incidence and Clinical Predictors of Stent Restenosis and Early Stent Occlusion in Patients with Acute Myocardial Infarction Treated by Bare Metal Stents: Importance of Infarct Location and Serum Creatinine Level

  2014cites this paper
• Current state of ST-segment myocardial infarction: evidence-based therapies and optimal patient outcomes in advanced systems of care.

  2014cites this paper
• Akutversorgung des akuten Myokardinfarktes

  2014cites this paper
• Stents: Safety and Efficacy

  2014cites this paper
• New Horizons of Acute Myocardial Infarction: From the Korea Acute Myocardial Infarction Registry

  2013cites this paper
• The efficacy and safety of drug-eluting stents in patients with acute myocardial infarction: results from Korea Acute Myocardial Infarction (KAMIR).

  2013cites this paper
• New concepts in the design of drug-eluting coronary stents

  2013cites this paper
• J-PCI Registry

  2013cites this paper
• The use of drug-eluting stents in acute myocardial infarction – is the battle coming to an end? From despair to acceptance

  2013cites this paper
• Chapter 11 – Advances in Coronary Revascularization

  2013cites this paper
• Improving smooth muscle cell exposure to drugs from drug-eluting stents at early time points: a variable compression approach

  2013cites this paper
• Outcomes With Various Drug-Eluting or Bare Metal Stents in Patients With ST-Segment–Elevation Myocardial Infarction: A Mixed Treatment Comparison Analysis of Trial Level Data From 34 068 Patient-Years of Follow-up From Randomized Trials

  2013cites this paper
• Outcome of ST-elevation myocardial infarction versus non-ST-elevation acute coronary syndrome treated with titanium-nitride-oxide-coated versus everolimus-eluting stents: insights from the BASE-ACS trial.

  2013cites this paper
• Clinical Outcomes from Unselected Real-World Patients with Acute Myocardial Infarction Receiving Biodegradable Polymer Coated Sirolimus-Eluting Stents

  2013influential citation
• Are the culprit lesions severely stenotic?

  2013cites this paper
• Avoiding stent thrombosis: advances in technique, antiplatelet pharmacotherapy and stent design

  2013cites this paper
• Rationale, design and baseline characteristics of a study to evaluate effects of candesartan on cardiovascular events after drug-eluting stent implantation in patients with ischemic heart disease.

  2013cites this paper
• Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis

  2013cites this paper
• Implementation of standardized assessment and reporting of myocardial infarction in contemporary randomized controlled trials: a systematic review.

  2013cites this paper
• Bare-metal stenting of large coronary arteries in ST-elevation myocardial infarction is associated with low rates of target vessel revascularization.

  2013cites this paper
• Predictors and clinical implications of stent thrombosis in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION trial.

  2013cites this paper
• Five-year clinical outcome of titanium-nitride-oxide-coated bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: long-term follow-up from the TITAX AMI trial.

  2013cites this paper
• Drug-coated balloon treatment in coronary artery disease: Recommendations from an Asia-Pacific Consensus Group

  2013cites this paper
• The Development of Novel Biodegradable Bifurcation Stents for the Sustainable Release of Anti-Proliferative Sirolimus

  2012cites this paper
• The HEART study: a real-world experience using the CID Chrono Carbostent in primary and rescue PCI

  2012cites this paper
• Cardiovascular Clinical Trials: Putting the Evidence into Practice

  2012cites this paper